Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.

× No keyword cloud information.

14 in total

1. Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.

Authors: J Mattern; M Kaufmann; H Hinderer; K Wayss; M Volm
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1975

Review 2. The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors: W Theuer; O Selawry; K Karrer
Journal: Med Oncol Tumor Pharmacother Date: 1992

3. Is adjuvant treatment with vinblastine effective in reducing the occurrence of distant metastasis in limited squamous cell lung cancer? A randomized study.

Authors: D C Schallier; W J De Neve; J L De Greve; S P Van Belle; G J De Wasch; G Dotremont; G A Storme
Journal: Clin Exp Metastasis Date: 1988 Jan-Feb Impact factor: 5.150

4. Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma.

Authors: J Mattern; M Kaufmann; K Wayss; M Volm
Journal: Klin Wochenschr Date: 1976-07-15

Review 5. N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors: D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

6. Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung.

Authors: R E Taylor; I E Smith; H T Ford; B M Bryant; A J Casey; J F Smyth
Journal: Cancer Chemother Pharmacol Date: 1980 Impact factor: 3.333

7. The combined modality approach in the treatment of inoperable small-cell anaplastic carcinoma of the lung.

Authors: R Osieka; C G Schmidt; H B Makoski; E Scherer
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1977-05-20

8. Comparison of survival in nonresected well differentiated and poorly differentiated adenocarcinoma of the lung.

Authors: N Saijo; H Niitani; K Tominaga; K Eguchi; H Koketsu; T Fujino; S Ishikawa
Journal: J Cancer Res Clin Oncol Date: 1980 Impact factor: 4.553

9. Combination chemotherapy (high-dose methotrexate with citrovorum factor rescue, mechlorethamine, and procarbazine) in non-small cell lung cancer.

Authors: R R Bhasin; C P Nogeirie
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

Review 10. Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors: J B Sørensen; M Clerici; H H Hansen
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333